+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Zymeworks Inc - logo

Zymeworks is a computational biotechnology company. The company's focus is in the research and development of industrial enzymes and protein therapeutics for chemical, and pharmaceutical industries. Zymeworks' approach combines proprietary molecular modeling and simulation software with high-performance computing to create an environment for in silico experimentation and predictive protein optimization. The products are based upon the company's molecular modeling software for optimizing protein structure. The company is based in Vancouver, British Columbia.

Synthetic Biology: Protein Design and Engineering Market by Type of Protein Engineering Approach Used, Type of Protein, Type of Application, Type of End User and Key Geographies: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Synthetic Biology: Protein Design and Engineering Market by Type of Protein Engineering Approach Used, Type of Protein, Type of Application, Type of End User and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • January 2022
  • 242 Pages
From
Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2015-2022 - Product Thumbnail Image

Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2015-2022

  • Report
  • April 2022
  • 350 Pages
From
Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022 - Product Thumbnail Image

Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022

  • Report
  • April 2022
  • 1000 Pages
From
Fc Protein and Glyco-engineered Antibodies Market: Focus on Type of Fc Engineering and Therapeutics (3rd edition), 2021-2030 - Product Thumbnail Image

Fc Protein and Glyco-engineered Antibodies Market: Focus on Type of Fc Engineering and Therapeutics (3rd edition), 2021-2030

  • Report
  • July 2021
  • 290 Pages
From
Masked Antibodies & Cytokines as Prodrugs: A Landscape Analysis of Stakeholders, Technologies, Pipelines, Business and Financing from An Industry Perspective - Product Thumbnail Image

Masked Antibodies & Cytokines as Prodrugs: A Landscape Analysis of Stakeholders, Technologies, Pipelines, Business and Financing from An Industry Perspective

  • Report
  • October 2021
  • 433 Pages
From
Intracellular Targets Made Druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: An Industry Analysis of Technologies, Stakeholders, Deals & Trends - Product Thumbnail Image

Intracellular Targets Made Druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: An Industry Analysis of Technologies, Stakeholders, Deals & Trends

  • Report
  • January 2018
  • 252 Pages
From
US Breast Cancer Drug Market, Drug Price, Dosage & Clinical Trials Insight 2026 - Product Thumbnail Image

US Breast Cancer Drug Market, Drug Price, Dosage & Clinical Trials Insight 2026

  • Report
  • January 2021
  • 900 Pages
From
Cell Line Development and Characterization Services by Sources of Cell Lines/Expression Systems, Applications of Cell Lines, and Geography: Industry Trends and Global Forecasts, 2020-2030 - Product Thumbnail Image

Cell Line Development and Characterization Services by Sources of Cell Lines/Expression Systems, Applications of Cell Lines, and Geography: Industry Trends and Global Forecasts, 2020-2030

  • Report
  • January 2021
  • 483 Pages
From
Contract Biomanufacturing Services Global Market - Product Thumbnail Image

Contract Biomanufacturing Services Global Market

  • Report
  • December 2018
  • 203 Pages
From
T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: A Business, Stakeholder, Technology and Pipeline Analysis - Product Thumbnail Image

T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: A Business, Stakeholder, Technology and Pipeline Analysis

  • Report
  • June 2019
  • 463 Pages
From
Ovarian Cancer (Oncology) - Drugs in Development, 2021 - Product Thumbnail Image

Ovarian Cancer (Oncology) - Drugs in Development, 2021

  • Report
  • December 2021
  • 5066 Pages
From
Anti-VEGF Antibodies: Global Technology Assessment, Market Analysis and Future Growth Trends - Product Thumbnail Image

Anti-VEGF Antibodies: Global Technology Assessment, Market Analysis and Future Growth Trends

  • Report
  • May 2018
  • 140 Pages
From
  • 12 Results (Page 1 of 1)
Loading Indicator